Growing mortality due to chronic disease influence the UK life science instrumentation market

Published: May 2021

The UK life science instrumentation market is projected to grow at a significant CAGR of around 5.7% during the forecast period (2021-2027). Significant rise in the mortality rate due to the high incidence of cancer and chronic diseases in the region has been a major concern for the country. Many research institutes are carrying research to find innovative solutions to cure human diseases such as, cell culture, next-generation sequencing that further require various tools and instrumentation. Therefore, growth in the research activities in the country for the treatment of various chronic diseases such as cancer, CVD in the country further encourages the demand of life science instrumentation in the country. 

Browse the full report description of "UK Life Science Instrumentation Market Size, Share & Trends Analysis Report by Technology (Chromatography, Spectroscopy, Polymerase Chain Reaction (PCR), Clinical Chemistry Analyzers, Immunoassays, Next Generation Sequencing (NGS), Flow Cytometry, Microscopy, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Hospitals &Laboratories) and Forecast 2019-2025" at https://www.omrglobal.com/industry-reports/uk-life-science-instrumentation-market

Overall, the colorectal cancer incidence is on rising in the country especially in men which may influence the need for cell culture techniques coupled with life science instrumentation. As per data of Office for National Statistics, between 2011 and 2016, a growth of 1.1% in total incidences of colorectal cancer has been observed whereas a down of 0.4% has been observed in the female. The incidence rate is going down; however, the total number of mortalities has been increased by nearly 4.8% combinedly in male and female. Additionally, per capita healthcare investment from the nation’s government and the public is higher than other emerging nations which aids in the significant market growth in the near future.

Market Coverage

Report Elements

Details

Study Period

2020-2027

Base year

2020

Forecast period

2021-2027

Segments Covered

By Technology and by End-User

Key Companies Profiled

BiomerieuxS.A., Carl Zeiss AG, Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific, Inc., Tecan Trading AG and others


Key questions addressed by the report

  • What is the market growth rate during the forecast period?
  • Which segment dominates the market in the base year?
  • Which segment will project the fastest growth in the market during the forecast period?
  • How will COVID-19 impact the market growth in 2020 and the coming years?

o Recovery Timeline

o Deviation from the pre-COVID forecast

o Most affected segment

o Recommendations 

  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

UK Life Science Instrumentation Market – Segmentation

By Technology

  • Chromatography
  • Spectroscopy
  • Polymerase Chain Reaction (PCR)
  • Clinical Chemistry Analyzers
  • Immunoassays
  • Next-Generation Sequencing (NGS)
  • Flow Cytometry
  • Microscopy 
  • Others (Centrifuges, Electrophoresis)

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Research Institutes 
  • Hospitals and Laboratories 

To learn more about this report request a free sample copy @  https://www.omrglobal.com/request-sample/uk-life-science-instrumentation-market